Miltenyi Biotec

Advanced Therapies London – what an incredible experience for us! We had two fantastic days showcasing our strengths in cell and gene therapy and reconnecting with forward-thinking industry leaders. Huge thanks to #Terrapinn for their amazing organization, which fostered new collaborations and sparked inspiring conversations. Thank you to everyone who stopped by our booth or attended the talk of our selected speaker, Dr. Dominika Lukas — we’re proud to be driving the future of CGT together!

Stories of patients with long term durable responses to cell and gene therapies make headlines in the media and bring hope to patients in need of treatment options. However, bridging the (cell therapy) gap between ATMP development and improved patient care requires navigating a complex and evolving landscape of variables. As stakeholders with a shared vision of accelerating improved patient outcomes through ATMPs, Flemingsberg Science Foundation and Miltenyi Biotec Nordics are proud to host an educational seminar aimed at highlighting challenges and opportunities in meeting patient needs at every step of the journey: from pre-GMP development through clinical trials. Join the engaged and supportive community of local cell therapy experts and enthusiasts in addressing the challenge of bringing more ATMP options to more patients, more efficiently. 📅 Tuesday, 6 May 2025 ⏲️ 12:00 - 18:00 🏢 Campus Flemingsberg, Jan-Åke Gustafsson seminar room, NEO building Register to attend on https://ow.ly/3gch50VoRa5

Meet Joshua Katz, a dedicated researcher in the Lee-Chang Lab at Northwestern University in Chicago. Joshua studies central nervous system (CNS) tumors, coming up with immune-based therapies to prevent tumor growth. At this lab a B cell-based therapy was developed to enhance anti-tumor responses using activated 4-1BBL⁺ B cells and CD8⁺ T cells in glioma-bearing mice. 🌟🧬 Joshua expressed impressive time-savings and significant boosts in viability and functionality when incorporating the StraightFrom® Spleen Kits into the protocol. https://ow.ly/Us3250VoKA9 #Spleen #Cellseparation #MBStories #MiltenyiBiotec

Your research. Our support. 4x the opportunity! We’re excited to announce the Miltenyi Biotec Pluripotent Stem Cell Research Travel Award for the ISSCR Annual Meeting 2025 in Hong Kong! This year, we’re offering FOUR awards! This is your chance to attend the world’s leading stem cell research event, showcase your groundbreaking work powered by Miltenyi Biotec technologies, and connect with global experts shaping the future of regenerative medicine. Submit your abstract today and secure your place at the forefront of innovation: https://ow.ly/pjCJ50ViVVx #ISSCR2025 #TravelAward #StemCellResearch #PSCInnovation #FutureofMedicine

Here we go, the 51st Annual Meeting of the EBMT this year in Florence, Italy! Join us at booth 34 to see how we can address your cellular therapy research challenges with our unique technologies. Also attend our Satellite Symposium to hear experts share the latest insights on... Topic: Expanding treatment options: ex vivo T cell depletion and point-of-care manufacturing of CAR T cell therapies Date: March 30, 2025, 2:30 p.m. – 4:00 p.m., Nazioni Hall Click through for further details on our speakers or technologies – see you there: https://ow.ly/8Izt50Vb5le

Can you believe what you are hearing? 🤯 These top researchers are telling how their spatial journeys have been and how great the experience has been with the MACSima™ Platform. See for yourself and dive into spatial biology! 🌊🔬🧬 Watch all interviews here: https://ow.ly/v3CJ50V9gV2 #SpatialBiology #MACSima #MultiOmics #MiltenyiBiotec

Are you using spatial biology for your cancer research? Apply for the Miltenyi Biotec EACR travel award and you could join us at EACR 2025 in Lisbon! ✈️🌍 Tell us how using spatial biology has revolutionized your cancer research and maybe the trip will be free for you! More details 👉 https://ow.ly/KybF50VazoS #EACR2025 #TravelAward #SpatialBiology #MiltenyiBiotec

Isolating immune cells from mouse spleen? Let’s make it easy! Forget the tedious steps and density gradient centrifugation – our StraightFrom® Spleen MicroBead and Isolation kits get the job done fast with minimal hands-on time. ✔️ Isolation of immune cells from spleen tissue in just 25 minutes ✔️ No centrifugation ✔️ No cell counting ✔️ No reagent calculations ✔️ Automation-ready for reproducible results Cut the complexity and focus on what really matters - learn more here: https://ow.ly/xWnX50V6KcL

Ready to take your cell therapy to the next level? Our BaEV LVV platform is here to revolutionize transduction for even the toughest cell types! 🔹 Superior transduction: Achieve higher efficiency with NK cells, HSCs, and γδ T cells and more - outperforming traditional vectors like VSV-G. 🔹 Optimized performance: designed for reliability and quality, with tranduction efficiency of 60-90% in NK and ydT cells* 🔹 Expand your reach: Unlock new possibilities with confidence using our proven, innovative LVV platform. Let’s push boundaries together: https://ow.ly/igJf50VaWWF * Based on data collected through 2024. Miltenyi Biotec does not guarantee that any specific delivery date(s) will be met. lndividual timelines may vary based on factors such as client's stage of development and specifications.

Join us for our first roundtable discussion for 2025 focusing on the different approaches to point-of-care manufacturing of cell and gene therapies, current tools, and regulatory frameworks shaping the field. Date: March 20, 2025 Time: 10:00 a.m. – 11:00 a.m. CET Topic: Point-of-care manufacturing models: GMP aspects and regulatory pathways. For more information on the panelists or to register your attendance - click here: https://ow.ly/V9Wo50V66a3